We are live on ! Find out more

RPRX

Repros Therapeutics Inc.

RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

80 hedge funds and large institutions have $379M invested in Repros Therapeutics Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New

Increased

Maintained

Reduced

Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

1% more funds holding

Funds holding: 79 → 80 (+1)

8% less capital invested

Capital invested by funds: $412M → $379M (-$32.8M)

17% less call options, than puts

Call options by funds: $10.6M | Put options by funds: $12.7M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders

Holders Change

Holders Change %

+1.27%

% of All Funds

2.31%

Holding in Top 10

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-50%

% of All Funds

0.03%

New

Increased

Reduced

Closed

Calls

$10.6M

Puts

$12.7M

Net Calls

-$2.1M

Net Calls Change

-$7.97M

Top Buyers

Rank	Fund	Capital Flow
1	RCM RA Capital Management Boston, Massachusetts	+$27.8M
2	OIM Oracle Investment Management Greenwich, Connecticut	+$24M
3	Franklin Resources San Mateo, California	+$15.8M
4	DCM Destrier Capital Management New York	+$3.89M
5	Susquehanna International Group Bala Cynwyd, Pennsylvania	+$2.49M

Top Sellers

Rank	Fund	Capital Flow
1	Jennison Associates New York	-$27.4M
2	Citadel Advisors Miami, Florida	-$23.8M
3	State Street Boston, Massachusetts	-$11.6M
4	WC Wexford Capital West Palm Beach, Florida	-$8.41M
5	PHS PFM Health Sciences San Francisco, California	-$8.24M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 D.E. Shaw & Co New York	$2.01M	-$1.63M	-84,179	-43%
27	GAI 27 General American Investors New York	$1.82M	–	–	–
28	TCIM 28 TIAA CREF Investment Management New York	$1.79M	+$239K	+12,355	+14%
29	29 Barclays London, United Kingdom	$1.69M	-$2.93M	-151,269	-60%
30	30 Goldman Sachs New York	$1.59M	+$514K	+26,574	+42%
31	DCM 31 Driehaus Capital Management Chicago, Illinois	$1.35M	+$139K	+7,167	+10%
32	32 Nomura Holdings Tokyo, Japan	$1.16M	+$3.85K	+199	+0.3%
33	BIM 33 BlackRock Investment Management Wilmington, Delaware	$1.13M	+$16.5K	+854	+1%
34	34 Citigroup New York	$1.05M	+$41K	+2,120	+4%
35	35 Allianz Asset Management Munich, Germany	$997K	-$66K	-3,412	-6%
36	36 Jane Street New York	$900K	+$981K	+50,712	New
37	TMC 37 Trellus Management Company Delray Beach, Florida	$887K	+$968K	+50,000	New
38	38 California Public Employees Retirement System Sacramento, California	$854K	–	–	–
39	PIM 39 Partner Investment Management San Francisco, California	$783K	-$86.9K	-4,492	-9%
40	40 Deutsche Bank Frankfurt Am Main Ge, Germany	$766K	-$410K	-21,187	-33%
41	41 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$741K	+$5.8K	+300	+0.7%
42	42 AllianceBernstein Nashville, Tennessee	$637K	+$98.7K	+5,099	+17%
43	TA 43 Teachers Advisors New York	$607K	–	–	–
44	44 Charles Schwab San Francisco, California	$581K	–	–	–
45	LP 45 LMR Partners London, United Kingdom	$564K	+$615K	+31,791	New
46	46 AQR Capital Management Greenwich, Connecticut	$500K	–	–	–
47	47 Dimensional Fund Advisors Austin, Texas	$470K	–	–	–
48	48 Swiss National Bank Zurich, Switzerland	$468K	+$120K	+6,200	+31%
49	MOACM 49 Mutual of America Capital Management New York	$442K	+$482K	+24,900	New
50	50 Morgan Stanley New York	$418K	-$69K	-3,568	-13%

RPRX Hedge Fund Activity: Q1 2014 in Review

80 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q1 2014, worth a combined $379M — down 8% from $412M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RPRX positions and 13 closed out — a net gain of 2 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $27.8M. The largest seller was Jennison Associates, exiting entirely with an estimated $27.4M sold.

80 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q1 2014, up from 79 in Q4 2013.
Funds reported $379M of Repros Therapeutics Inc. stock for Q1 2014, down 8% quarter-over-quarter.
15 funds opened new Repros Therapeutics Inc. positions in Q1 2014 and 13 closed out, a net change of +2 holders.
The largest Repros Therapeutics Inc. buyer in Q1 2014 was RA Capital Management, an estimated $27.8M added.
The largest Repros Therapeutics Inc. seller in Q1 2014 was Jennison Associates, an estimated $27.4M sold.

Based on aggregated 13F filings for Q1 2014.

Repros Therapeutics Inc. RPRX